Home  English Website Company Sales companies Belgium

International sales activities

Belgium

In Belgium STADA has its own sales companies in Brussles named S.A. Eurogenerics N.V. and S.A. Neocare N.V.

In Belgium, STADA recorded a sales plus in the first three months of the current financial year in the amount of 13% to EUR 39.9 million (1-3/2011: EUR 35.2 million). The positive development was attributable to, among other things, a so-called early entry of Atorvastatin¹⁾, which allowed STADA, due to the purchase of the corresponding rights, a market entry with its own generic product for this active ingredient in the Belgian market two months before the actual patent expiration.

With a sales increase of 15% to EUR 38.2 million (1-3/2011: EUR 33.3 million), the Group continued to have the largest share of local sales with generics in the Belgian market. The share of generics amounted to 96% of STADA’s sales in Belgium (1-3/2011: 95%).

The sales achieved by STADA with branded products in Belgium decreased by 9% to EUR 1.7 million (1-3/2011: EUR 1.9 million). Branded products thereby contributed 4% to sales achieved by STADA in Belgium (1-3/2011: 5%).

For the financial year 2012, STADA calculates a renewed sales increase with operating profitability at about Group average in the Belgian market.

1)	For the treatment of hypercholesterolemia.

1)	Sales below EUR 0.05 million were rounded to EUR 0.0 million.

www.eurogenerics.be

Note: This website is only accessible to medical and pharmaceutical specialists with a personal password.